These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 25219651)
21. Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib. Berna R; Hasbun T; Adams D; Moon AT; Treat JR Pediatr Dermatol; 2024; 41(5):936-937. PubMed ID: 38886992 [TBL] [Abstract][Full Text] [Related]
22. Hereditary spastic paraplegia masqueraded by congenital melanocytic nevus syndrome: Dual pathogenesis of germline non-mosaicism and somatic mosaicism. Sakaguchi Y; Uehara T; Sasaki M; Fujimura K; Kishi K; Kosaki K; Takenouchi T Eur J Med Genet; 2020 Apr; 63(4):103803. PubMed ID: 31698101 [TBL] [Abstract][Full Text] [Related]
23. Acquisition of Somatic NRAS Mutations in Central Nervous System Melanocytes: A Predisposing Risk Factor to Primary Melanoma of the Central Nervous System, a Frequently Forgotten Pitfall in Congenital Nevi. Garrido MC; Maroñas-Jiménez L; Morales-Raya C; Ruano Y; Rodriguez-Peralto JL Am J Dermatopathol; 2018 Jul; 40(7):506-510. PubMed ID: 29077579 [TBL] [Abstract][Full Text] [Related]
24. Phenotype/genotype correlations in epidermal nevus syndrome as a neurocristopathy. Flores-Sarnat L; Sarnat HB Handb Clin Neurol; 2015; 132():9-25. PubMed ID: 26564069 [TBL] [Abstract][Full Text] [Related]
25. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus. Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623 [No Abstract] [Full Text] [Related]
26. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891 [TBL] [Abstract][Full Text] [Related]
27. A Symmetric Eczematous Eruption Harboring Thousands of Melanocytic Lesions. Ratushny V; Kraft S; Moschella SL; Duncan LM; Lawrence DP; Tsao H JAMA Dermatol; 2016 Sep; 152(9):1021-4. PubMed ID: 27192392 [TBL] [Abstract][Full Text] [Related]
28. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy. Lim YH; Ovejero D; Derrick KM; ; Collins MT; Choate KA J Am Acad Dermatol; 2016 Aug; 75(2):420-7. PubMed ID: 27444071 [TBL] [Abstract][Full Text] [Related]
29. Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract. Tseng D; Kim J; Warrick A; Nelson D; Pukay M; Beadling C; Heinrich M; Selim MA; Corless CL; Nelson K J Am Acad Dermatol; 2014 Aug; 71(2):229-36. PubMed ID: 24842760 [TBL] [Abstract][Full Text] [Related]
30. Detection of a multilineage mosaic NRAS mutation c.181C>A (p.Gln61Lys) in an individual with a complex congenital nevus syndrome. Ulrich M; Tinschert S; Siebert E; Franke I; Tüting T; Ulrich J; Schanze D; Wieland I; Zenker M Pigment Cell Melanoma Res; 2019 May; 32(3):470-473. PubMed ID: 30548225 [No Abstract] [Full Text] [Related]
31. Mosaic RASopathies concept: different skin lesions, same systemic manifestations? Morren MA; Fodstad H; Brems H; Bedoni N; Guenova E; Jacot-Guillarmod M; Busiah K; Giuliano F; Gilliet M; Atallah I J Med Genet; 2024 Apr; 61(5):411-419. PubMed ID: 38290824 [TBL] [Abstract][Full Text] [Related]
33. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations. Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C; Aguilera P; Brualla D; Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J J Invest Dermatol; 2019 Apr; 139(4):900-908. PubMed ID: 30359577 [TBL] [Abstract][Full Text] [Related]
34. Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi. Aimaier R; Chung M; Zhu H; Yu Q Exp Dermatol; 2022 Apr; 31(4):582-585. PubMed ID: 35020224 [TBL] [Abstract][Full Text] [Related]
35. BRAF mutations are common somatic events in melanocytic nevi. Kumar R; Angelini S; Snellman E; Hemminki K J Invest Dermatol; 2004 Feb; 122(2):342-8. PubMed ID: 15009715 [TBL] [Abstract][Full Text] [Related]
36. NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi. Tschandl P; Berghoff AS; Preusser M; Burgstaller-Muehlbacher S; Pehamberger H; Okamoto I; Kittler H PLoS One; 2013; 8(7):e69639. PubMed ID: 23861977 [TBL] [Abstract][Full Text] [Related]
37. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases. Donati M; Martinek P; Kastnerova L; Persichetti P; Michal M; Kazakov DV Am J Dermatopathol; 2020 Dec; 42(12):961-966. PubMed ID: 32769548 [TBL] [Abstract][Full Text] [Related]
38. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715 [TBL] [Abstract][Full Text] [Related]
39. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation. Tan JM; Tom LN; Jagirdar K; Lambie D; Schaider H; Sturm RA; Soyer HP; Stark MS Br J Dermatol; 2018 Jan; 178(1):191-197. PubMed ID: 28714107 [TBL] [Abstract][Full Text] [Related]